News
On June 9, Regeneron Pharmaceuticals and Sanofi (NASDAQ:SNY) announced promising interim results from the open-label Phase 4 ...
Avanza Fonder AB reduced its holdings in Regeneron Pharmaceuticals by 14.5% in the first quarter, still maintaining $5.57 million in shares. Several heavyweight institutional investors continued to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback